Pharmaceutical News

RSS

New research provides welcomed news for countless patients taking PPIs

For patients taking proton pump inhibitors to treat gastroesophageal disease (GERD) or other acid-related conditions, new research puts safety concerns to rest.

7 Jun 2019

Still-to-be-approved drug proves to be new option for treating active rheumatoid arthritis

In a large-scale, international study led by renowned rheumatologist Josef Smolen from the Department of Medicine III, a still-to-be-approved drug containing the selective janus kinase inhibitor upadacitinib has proved itself to be a new option for treating active rheumatoid arthritis.

7 Jun 2019

New study examines non‐medical use of anti-anxiety medication

There is concern about the misuse of the sedative anti-anxiety medication alprazolam (Xanax®) because of the "high" it can create.

6 Jun 2019

FDA approves first vaccine for prevention of dengue disease in endemic regions

The U.S. Food and Drug Administration announced today the approval of Dengvaxia, the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes (1, 2, 3 and 4) in people ages 9 through 16 who have laboratory-confirmed previous dengue infection and who live in endemic areas.

6 Jun 2019

Antihypertensive drug use linked with reduction in dementia risk

Various clinical trials indicate what effects can be expected from standardized intervention programs on the basis of existing evidence.

3 Jun 2019

Targeted breast cancer therapy shows 'encouraging' results

Researchers have developed a targeted therapy that may significantly increase the survival of pre-menopausal women with advanced breast cancer

3 Jun 2019

Countries' essential medicines lists differ from one another and WHO's model list, study finds

Countries' essential medicines lists vary from one another and from the World Health Organization's model list, pointing to a potential need for greater care in selecting medicines that best meet the health care priorities of a population, suggests a study led by Toronto's St. Michael's Hospital.

3 Jun 2019

Body's endocannabinoid system appears to be new target for drug development against OCD

The body's endocannabinoid system, due to the critical role it plays in regulating neurotransmitter signaling, is an enticing target for drug development against disorders associated with anxiety, stress, and repetitive behaviors, such as obsessive-compulsive disorder.

3 Jun 2019

Study: 81% of antibiotics prescribed by dentists to prevent infections are unnecessary

A new study conducted by researchers at the University of Illinois at Chicago and published in JAMA Network Open has found that 81% of antibiotics prescribed by dentists - who are among the top prescribers in the U.S., accounting for about 10% of all antibiotic prescriptions - to prevent infections prior to dental visits are unnecessary.

31 May 2019

Study links heartburn drugs to fatal cases of heart, kidney disease and gastrointestinal cancer

Extended use of popular drugs to treat heartburn, ulcers and acid reflux has been associated with an increased risk of premature death. However, little has been known about the specific causes of death attributed to the drugs.

30 May 2019

Metabolite of kratom alkaloid could be responsible for its pain relief benefits

Kratom is a Southeast Asian tree with a long history of use in traditional medicine.

30 May 2019

ZwickRoell appoints Michael Goehring as Medical and Pharmaceutical Industry Manager

ZwickRoell in North America is pleased to announce the strengthening of its expertise in medical and pharmaceutical materials testing with the addition of Michael Goehring as Medical and Pharmaceutical Industry Manager.

29 May 2019

Patients reading clinician visit notes report positive effects on use of prescription medications

A new study of patients reading the visit notes their clinicians write, report positive effects on their use of prescription medications.

29 May 2019

Oklahoma’s ‘precedent-setting’ suit puts opioid drugmakers on trial

All eyes will be on Oklahoma this week when the first case in a flood of litigation against opioid drug manufacturers begins Tuesday.

28 May 2019

ISPOR examines the issue of patient access and biosimilars

ISPOR the professional society for health economics and outcomes research, examined the issue of patient access and biosimilars this afternoon at its ISPOR 2019 annual conference with the session, "Improving Patient Access to Life Saving Therapies: What Needs to Be Done to Fulfill the Promise of Biosimilars?"

26 May 2019

US dentists write more opioid prescriptions than England dentists

Researchers from the University of Illinois at Chicago have found that dentists practicing in the U.S. write 37 times more opioid prescriptions than dentists practicing in England.

25 May 2019

New encyclopedia focuses on pharmacy practice and clinical pharmacy

A MAJOR new reference work conceived and edited by the University of Huddersfield's Professor Zaheer-Ud-Din Babar will have a global readership and breaks new ground with its analysis of the latest developments in the pharmacy profession.

24 May 2019

Short-term opioid use increases the positivity of emotional experiences

The human opioid system contributes to the regulation of emotions, pleasure and pain. Opioids are strong analgesics. In addition to effectively relieving pain, external opioids may improve mood and reduce negative emotions.

24 May 2019

Marijuana use episodes among couples increase likelihood of intimacy events

Marijuana use episodes among couples who frequently use the drug increase the likelihood of experiencing intimacy events, according to the results of a University at Buffalo-led study.

23 May 2019

Study reveals a better way to help increase support for vaccinations

The re-introduction of measles, mumps and other previously eradicated diseases to the United States is nothing short of a public health crisis. Since Jan. 1, a staggering 880 individual cases of measles have been confirmed in 24 states -- the greatest number of cases since 1994. Measles was declared eliminated in the U.S. in 2000.

23 May 2019